High-entropy herringbone alloy
Eutectic high-entropy alloys have a dual phase structure that could be useful for optimizing a material’s properties. Shi
et al
. found that directional solidification of an aluminum-iron-cobalt-nickel eutectic high-entropy alloy created a herringbone-patterned microstructure that was extremely resistant to fracture (see the Perspective by An). The structure contained lamellae of hard and soft phases, and the cracks that formed in the hard phase were arrested at the boundary of the soft phase. This, along with stress transfer, allowed a tripling of the maximal elongation while retaining high strength. —BG
Multiferroic phase-transforming alloys demonstrate intriguing multicaloric effects, but they are intrinsically brittle and their elastocaloric effect shows poor cyclability, which remains a major challenge for exploiting more efficient multicaloric refrigeration. Here, by employing a novel strategy of strengthening grain boundary, the cyclability of elastocaloric effect in the prototype Ni-Mn-based multiferroic phase-transforming alloys is strikingly enhanced by two orders of magnitude. Ultrahigh cyclability of a large elastocaloric effect is achieved. This not only paves the way for exploiting multicaloric effects for more efficient cooling, but also provides a strategy for overcoming the cyclability issues in the ubiquitous brittle intermetallic phase-transforming materials.
IMPACT STATEMENTThe cyclability of elastocaloric effect in the prototype Ni-Mn-based multiferroic phase-transforming alloys has been strikingly enhanced by two orders of magnitude through employing the strategy of strengthening grain boundary.
ARTICLE HISTORY
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.